Search

everythinglearnresearchcommunity

for

Search:↓

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Some common medications can harm male fertility, but many effects can be reversed.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Apoptosis is crucial for healthy skin and treating skin diseases.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Melatonin improved mental health and metabolism in women with PCOS.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Smoking harms skin health, causing slower wound healing, more wrinkles, and worsening some skin conditions, but may protect against certain others.

The review suggests that understanding and treating the psychological aspect of skin disorders is important and calls for more collaboration in this field.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Valproic acid increases hair count in men with hair loss.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Immune cells affect hair growth and could lead to new hair loss treatments.

Finasteride use may lead to less alcohol consumption in men with lasting sexual side effects.